AstraZeneca Pharma India shares may be in focus after the company announced a second brand partnership with Sun Pharma to ...
In the phase 2 MIRO-CKD trial, investigators tested a novel MRA in combination with an SGLT2 inhibitor and included patients with higher serum potassium levels than 4.8 mmol/L at baseline and patients ...
Unhealthy diets are a major impediment to achieving a healthier population in the United States. Although there is a relatively clear sense of what constitutes a healthy diet, most of the US ...
New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has recommended approval for AstraZeneca India Pharma Limited's proposal to ...